What is 4D Molecular Therapeutics's capex?

4D Molecular Therapeutics (FDMT) reported capex of $0 in Q1 2026.

How has 4D Molecular Therapeutics's capex changed year-over-year?

4D Molecular Therapeutics's capex decreased by 100.0% year-over-year, from $631K to $0.

What is the long-term trend for 4D Molecular Therapeutics's capex?

Over 3 years (2021 to 2024), 4D Molecular Therapeutics's capex has grown at a -25.4% compound annual growth rate (CAGR), from $9.11M to $3.79M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

4D Molecular Therapeutics FDMT CapEx

CapEx at other companies

Eli LillyLLY

$2.33B+54.0%

Regeneron PharmaceuticalsREGN

$230.6M+0.6%

Vertex PharmaceuticalsVRTX

$133.4M+228%

EyePoint, Inc. EYPT

$997K+261%

AbbVieABBV

$265M+12.8%

RegenxbioRGNX

$1.24M+20.6%

Other financials

Income statement

See full

Revenue$3.0M+21,664%

Operating income-$73.6M-37.3%

Net income-$68.8M-43.3%

EPS (diluted)-$1.01-17.4%

Balance sheet

See full

Cash & equivalents$72.5M-45.7%

Total debt$20.5M-13.9%

Total equity$451.8M-3.8%

Total assets$512.9M-0.5%

Cash flow

See full

Operating cash flow-$68.1M-42.6%

Free cash flow-$68.1M-40.8%

Valuation

See full

Market cap$602.22M+215%

Enterprise value$550.27M+574%

P/S6.8×-8,306×

Profitability

See full

Operating margin-220.1%-110pp

Net margin-174,314.2%-62,763pp

FCF margin-154,209.2%-53,057pp

Returns & leverage

See full

Return on equity-45.4%+29.8pp

Debt / equity0×0.0×

Current ratio9.3×-3.0×

Where this comes from

Reported directly by 4D Molecular Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 4D Molecular Therapeutics's capex?: 4D Molecular Therapeutics (FDMT) reported capex of $0 in Q1 2026.
How has 4D Molecular Therapeutics's capex changed year-over-year?: 4D Molecular Therapeutics's capex decreased by 100.0% year-over-year, from $631K to $0.
What is the long-term trend for 4D Molecular Therapeutics's capex?: Over 3 years (2021 to 2024), 4D Molecular Therapeutics's capex has grown at a -25.4% compound annual growth rate (CAGR), from $9.11M to $3.79M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.